Catherine M Albert

4PUBLICATIONS
64CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 18, 2026
The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Jan 27, 2025
Elective Discontinuation of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas and Related Mesenchymal Tumors.

Leo Mascarenhas, Steven G DuBois, Catherine M Albert

|Sep 10, 2024
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Navin Pinto, Catherine M Albert, Mallory R Taylor

|Oct 19, 2022
Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang

Pageof 1

Frequent Collaborators

3 joint publications

Ashley L Wilson

3 joint publications

Wenjun Huang

3 joint publications

Christopher Brown

3 joint publications

Joshua Gustafson